What did @chloe_khloe2 actually say?
Honestly, it's hard to fact-check this one in the traditional sense. The transcript is incoherent. The creator repeats the word "Japan" over a dozen times with no discernible medical claim attached. The caption, written in Haitian Creole, does the actual heavy lifting: it states that Ozempic is a medication for diabetics and that when people take it, they lose weight.
So the video's substantive claims live in the caption, not the spoken content. The caption translates roughly to: "Ozempic is a medication for people with diabetes. When people take this medication, it makes them lose weight." That's the claim we can evaluate. The spoken audio appears to be either a technical glitch, a CapCut editing artifact, or filler content that was never meant to carry medical information.
Does the science back this up?
The caption's two core claims are both accurate, as far as they go. Semaglutide, sold as Ozempic for type 2 diabetes and Wegovy for obesity, does have FDA approval for both conditions. The weight loss effect is real and well-documented in clinical trials.
The SUSTAIN trial program confirmed semaglutide's glycemic benefits in type 2 diabetes (Marso et al., 2016, New England Journal of Medicine). The STEP 1 trial showed adults without diabetes losing an average of 14.9% of body weight on 2.4mg weekly semaglutide versus 2.4% on placebo (Wilding et al., 2021, NEJM). So yes, it does make many people lose weight, and yes, it was originally developed for diabetes. Both statements check out at a basic level.
What the caption skips is the mechanism, the caveats, the side effects, and the fact that weight loss is not universal or permanent without continued use.
What did they get wrong (or right)?
The caption gets the basics right but strips away everything that would actually help a viewer make an informed decision. Calling Ozempic simply a medication "for people with diabetes" is incomplete. Ozempic (semaglutide 0.5mg, 1mg, 2mg) is FDA-approved for type 2 diabetes. Wegovy (semaglutide 2.4mg) is the separate FDA-approved formulation for chronic weight management. They are not interchangeable by label, even though the active molecule is the same.
The claim that the drug "makes" people lose weight also flattens a more complicated reality. Response varies significantly between individuals. Davies et al. (2021, Diabetes Care) noted that a subset of patients see minimal weight loss. Discontinuation typically leads to weight regain, as shown by Wilding et al. (2022, Diabetes, Obesity and Metabolism). The caption implies a straightforward cause-and-effect that the clinical data complicates.
The spoken transcript contributes nothing medically and should not be interpreted as containing health guidance of any kind.
What should you actually know?
If you saw this video and are wondering whether semaglutide could help you, here is what the evidence actually supports. GLP-1 receptor agonists like semaglutide work by mimicking the hormone GLP-1, which slows gastric emptying, increases insulin secretion in response to glucose, and reduces appetite signaling in the brain.
The weight loss and glycemic benefits are real. But these are prescription medications with a documented side effect profile, including nausea, vomiting, gastroparesis risk, and a boxed warning about thyroid C-cell tumors based on rodent studies. They are not appropriate for everyone. People with a personal or family history of medullary thyroid carcinoma or MEN2 should not use them.
Compounded semaglutide, which has been widely available during Ozempic and Wegovy shortages, is not the same as the FDA-approved brand-name products. Do not assume they are equivalent. If you are considering any GLP-1 therapy, talk to a licensed provider who can evaluate your full medical history, not a TikTok caption.
Bottom line
The caption's claims are directionally accurate but thin to the point of being misleading by omission. The spoken content is medically meaningless. A viewer walking away from this video might reasonably think Ozempic is a simple, reliable weight loss drug for diabetics, which misses most of what actually matters about how these medications work, who they are for, and what the risks are.